Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreement's diligence requirements. Each report will describe, where relevant:
Appears in 2 contracts
Samples: Exclusive License Agreement, Exclusive License Agreement
Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreement's ’s diligence requirements. Each report will describe, where relevantre levant:
Appears in 1 contract
Samples: Exclusive License Agreement
Diligence Report. 4.3.1 By March 1 [**] of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT Exhibit C and shall include information reasonably sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreement's ’s diligence requirements. Each report will describe, where relevant:
Appears in 1 contract
Samples: Exclusive License Agreement (Tokai Pharmaceuticals Inc)
Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreement's Agreements diligence requirements. Each report will describe, where relevant:
Appears in 1 contract
Samples: Exclusive License Agreement (SignPath Pharma, Inc.)